Management of Acute Urethritis in a Young Male After Unprotected Intercourse
This 21-year-old male presenting with dysuria and urinary frequency one day after unprotected intercourse should be treated empirically with dual therapy covering both gonorrhea and chlamydia—specifically ceftriaxone plus either azithromycin or doxycycline—initiated immediately without waiting for test results. 1
Immediate Diagnostic Approach
Obtain nucleic acid amplification tests (NAATs) for Neisseria gonorrhoeae and Chlamydia trachomatis at the time of clinical diagnosis, but do not delay treatment while awaiting results. 1, 2 The timing (one day post-exposure) and clinical presentation strongly suggest sexually transmitted urethritis rather than a typical urinary tract infection.
Confirming Urethritis
Attempt to document objective evidence of urethral inflammation using at least one of the following criteria: 1
- Visible urethral discharge on examination
- Positive leukocyte esterase test on first-void urine
- ≥10 white blood cells per high-power field in first-void urine sediment microscopy
If clinic-based diagnostic tools (such as Gram-stain microscopy) are unavailable, proceed directly to empiric treatment rather than delaying therapy. 1
Empiric Treatment Regimen
First-Line Therapy
Administer dual therapy covering both gonorrhea and chlamydia: 1, 3
- Ceftriaxone (for gonorrhea coverage) PLUS
- Azithromycin 1 g orally as a single dose OR Doxycycline 100 mg orally twice daily for 7 days (for chlamydia coverage)
Azithromycin has the advantage of single-dose administration, which improves compliance and allows for directly observed therapy. 1 Additionally, azithromycin is more effective than doxycycline against Mycoplasma genitalium, an increasingly recognized cause of persistent urethritis. 1
Dispense medications on-site in the clinic and directly observe the first dose to maximize compliance. 1
Alternative Regimens (if first-line unavailable)
If azithromycin or doxycycline cannot be used: 1
- Erythromycin base 500 mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
- Levofloxacin 500 mg orally once daily for 7 days
- Ofloxacin 300 mg orally twice daily for 7 days
Critical Patient Counseling
Sexual Abstinence
Instruct the patient to abstain from all sexual intercourse for at least 7 days after single-dose therapy (or until completion of a 7-day regimen) AND until all symptoms have completely resolved. 1, 2 This minimizes both ongoing transmission and risk of reinfection.
Partner Management
All sexual partners from the preceding 60 days must be notified, evaluated, and treated empirically for both gonorrhea and chlamydia, regardless of their test results. 2 Expedited partner treatment—providing prescriptions for partners who have not been examined—is advocated by the CDC and approved in many states. 3
Additional Screening
Screen this patient for other sexually transmitted infections, including syphilis and HIV, at the initial visit. 2 The presence of one STI significantly increases the likelihood of coinfection, and identifying these conditions early improves outcomes and reduces transmission.
Follow-Up Strategy
Repeat Testing
Schedule repeat NAAT testing for gonorrhea and chlamydia 3–6 months after treatment completion. 2 Reinfection rates are extremely high in this population, and many "treatment failures" are actually new infections from untreated partners or new exposures.
Persistent Symptoms
If symptoms persist after initial treatment and repeat testing is negative for gonorrhea and chlamydia, consider testing for Mycoplasma genitalium, which is an increasingly recognized cause of persistent urethritis. 4 Other less common pathogens include Trichomonas species, adenovirus, and herpes simplex virus. 3
Common Pitfalls to Avoid
Do not treat this as a simple urinary tract infection with fluoroquinolone monotherapy or trimethoprim-sulfamethoxazole. 5 Young sexually active males presenting with dysuria after unprotected intercourse have urethritis from STIs, not typical UTIs caused by E. coli. 4, 5
Do not wait for culture results before initiating treatment. 1 Early treatment prevents complications, reduces transmission (including HIV transmission, as urethritis increases HIV concentration in semen), and improves partner outcomes. 3
Do not assume treatment failure if the patient was reexposed to an untreated partner. 2 This underscores the critical importance of partner treatment—treating the index patient alone without addressing partners leads to the "ping-pong" effect of reinfection.